Comprehensive-Care for Multimorbid Adults Effectiveness Study
NCT ID: NCT01811173
Last Updated: 2015-04-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
1800 participants
INTERVENTIONAL
2013-03-31
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Enhanced Care for Patients With Complex Multimorbidity in Primary Care
NCT05676541
Improved Delivery of Cardiovascular Care Through Outreach Facilitation
NCT00574808
Effect of a Community-based Nursing Intervention on Mortality in Chronically Ill Older Adults
NCT01071967
Nurse vs General Practitioner Care for Patients Requesting Same Day Consultations in Primary Care
NCT00461201
Primary Healthcare for Community Living Old Elderly
NCT00452465
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients in the intervention group who agreed and signed the consent form to participate in the study will receive treatment by the physician - nurse team in accordance with the components of the Clalit's Comprehensive Care for Mutlimorbid Adults Project model. Components of the intervention include:
1. Comprehensive assessment of the patient's and family's needs
2. Coordinated care plan based on integrated care guides
3. "Multimorbid Action Plan" for patients
4. All-inclussive patient centered care and caregiver support
5. Proactive monitoring according to the plan.
Patients in the control groups will receive usual care in their primary care clinics. The Usual Care Survey control group will complete study questionnaires at 6, 12 and 24 months after enrollement.
The Usual Care Blinded group will be assessed only retrospectively based on deidentified information from Clalit's admistrative databases.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nurse-physician comprehensive care
Comprehensive self management support and care coordination by a nurse-primary care physician team
Nurse-physician comprehensive care
Components of the intervention include:
1. Complete assessment of the patient's and family's needs conducted by the nurse.
2. Comprehensive treatment program developed by the nurse and in consultation with the primary care physician.
3. "Multimorbid care plan" integrating all care aspects.
4. "Action Plan" for patients, supporting self management
5. Proactive monitoring according to the plan.
Usual care survey control group
Patients will receive usual primary care and asked to complete questionnaires on four time points throughout the study
No interventions assigned to this group
Usual care blinded control group
Patients will receive usual primary care.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nurse-physician comprehensive care
Components of the intervention include:
1. Complete assessment of the patient's and family's needs conducted by the nurse.
2. Comprehensive treatment program developed by the nurse and in consultation with the primary care physician.
3. "Multimorbid care plan" integrating all care aspects.
4. "Action Plan" for patients, supporting self management
5. Proactive monitoring according to the plan.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 and older
* 2 or more chronic conditions
Exclusion Criteria
* Participation in any medical research.
* Confined to bed.
* Inpatient nursing care, nursing homes.
* Kidney, liver or heart transplant patients.
* Active (receipt of oncology chemotherapy , radiotherapy or other oncology treatment during the past 3 years).
* Dialysis patients.
* Clalit Healthcare Services employees.
* Patients with major active mental illness, such as schizophrenia.
* Cognitive failure.
* Non Hebrew speaking patients without Hebrew speaking primary informal caregiver.
* Bedridden patients
* Housebound patients
18 Years
95 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Israel National Institute for Health Policy and Health Services Research
OTHER_GOV
Meir Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ran D Balicer, PhD
Role: PRINCIPAL_INVESTIGATOR
Clalit Research Institute, Clalit Health Services
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ashdod A
Ashdod, , Israel
Ashdod D
Ashdod, , Israel
Azur
Azor, , Israel
Arlozorov
Bat Yam, , Israel
Hashikma
Bat Yam, , Israel
Ramat Yosef
Bat Yam, , Israel
Sokolov
Bat Yam, , Israel
Halutz
Hulon, , Israel
Shikun Ammi
Hulon, , Israel
Lod Center
Lod, , Israel
Ramla Ztafon
Ramla, , Israel
Balfur
Rishon LeZiyyon, , Israel
Migdal HaIr
Rishon LeZiyyon, , Israel
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Cohen-Stavi CJ, Giveon S, Key C, Molcho T, Balicer R, Shadmi E. Guideline deviation and its association with specific chronic diseases among patients with multimorbidity: a cross-sectional cohort study in a care management setting. BMJ Open. 2021 Jan 11;11(1):e040961. doi: 10.1136/bmjopen-2020-040961.
Steinman MA, Low M, Balicer RD, Shadmi E. Impact of a nurse-based intervention on medication outcomes in vulnerable older adults. BMC Geriatr. 2018 Sep 6;18(1):207. doi: 10.1186/s12877-018-0905-1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CCMAP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.